Sample evaporation and concentration are critical steps in many R&D workflows, but inefficiencies can slow processes and impact results. The miVac centrifugal evaporator/concentrator range, available from Biopharma Group in the UK and Ireland, is engineered to overcome these challenges with superior performance, reliability, and ease of use.
A key innovation in the miVac range is the SpeedTrap™ condenser, which efficiently captures solvent vapours before they reach the pump. Unlike traditional bowl condensers that rely on glycol and multiple heat transfer layers, SpeedTrap™ ensures direct vapour contact with the cooling coil, improving condensation efficiency. This design reduces maintenance, extends pump lifespan, and enhances solvent recovery, all while minimising environmental impact.
Another standout feature is the precisely controlled evaporation chamber. Unlike many competitors that offer broad temperature adjustments, the miVac allows for fine-tuned settings, ensuring optimal conditions for different solvents. The system also includes aluminium monoblock rotors—far superior to plastic alternatives in heat conduction—resulting in faster evaporation times and greater consistency.
To further refine performance, the miVac features a pressure regulator and ramp control, preventing solvent bumping and optimising vapor capture. For those working with aqueous samples, an optional freeze-drying kit expands its versatility, allowing small-scale lyophilisation alongside evaporation processes.
Compact, efficient, and cost-effective, the miVac is an essential tool for labs looking to streamline evaporation and concentration workflows. Whether handling DNA, RNA, or complex solvent mixtures, the miVac delivers consistent, high-quality results.
